First-ever RSV vaccine could be approved, roll out by August
A vaccine to protect against severe cases of Respiratory Syncytial Virus could roll out as early as August. Pfizer has developed RSVpreF, a vaccine to prevent severe cases of RSV, and the Food and Drug Administration is reportedly expediting its review approval process. The FDA is expected to make their decision in August — just … Read more